Celanese (CE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Feb, 2026Executive summary
Achieved $773M free cash flow in 2025, supporting deleveraging and future growth despite a 7% sales decline and year-over-year earnings drop, with a focus on cost reduction and balance sheet strength.
Completed key actions including debt refinancing, divestitures (notably Micromax®), and $120M in cost reductions.
Maintained robust performance in Engineered Materials and Acetyl Chain segments despite soft demand.
Full year U.S. GAAP diluted loss per share was $(10.44), with adjusted EPS at $3.98, mainly due to $1.6B in impairment charges.
Strategic focus on free cash flow, sustainable business model changes, and top-line growth.
Financial highlights
FY2025 operating EBITDA: $1.2B in Engineered Materials, $950M in Acetyl Chain; both segments maintained over 20% EBITDA margin.
2025 consolidated operating loss of $786M, adjusted EBIT of $1.2B, and operating EBITDA of $1.9B, with margins of (8)%, 12%, and 20%.
Q4 2025 free cash flow was $160M; adjusted EPS was $0.67.
Working capital contributed $390M to free cash flow in 2025; targeting an additional $100M reduction in 2026.
Lanaken plant closure expected to deliver $20M–$25M in annual cost benefits, with $5M–$10M realized in 2026.
Outlook and guidance
FY2026 free cash flow guidance is $650M–$750M, achievable even in low-demand scenarios through additional levers.
Q1 2026 adjusted EPS guidance: $0.70–$0.85; Q1 2026 adjusted EBIT guidance: $210M–$230M for Engineered Materials, $110M–$125M for Acetyl Chain.
Expecting $1–$2 EPS uplift in 2026 versus 2025, with growth weighted to the second half due to turnaround activity in Q2.
Demand across most end-markets remains soft entering 2026; ongoing focus on earnings improvement.
Engineered Materials expected to drive growth, while Acetyl Chain faces more challenges but opportunities for improvement.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014